Characterization and ontogeny of P1‐purinoceptors on rat vas deferens
Open Access
- 1 March 1993
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 108 (3) , 754-758
- https://doi.org/10.1111/j.1476-5381.1993.tb12873.x
Abstract
1 The P1-purinoceptors which mediate the inhibition by adenosine of nerve-mediated contraction of the rat vas deferens have been investigated by use of the agonists N6-cyclopentyladenosine (CPA) and 5′-N-ethylcarboxamidoadenosine (NECA) and the A1-selective antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX). The ontogeny of the responses to adenosine and to the two co-transmitters which induce the contractions in this tissue, adenosine 5′-triphosphate (ATP) and noradrenaline (NA), have also been studied. 2 The order of potency for the adenosine agonists in inhibiting the nerve-mediated contractions was CPA = NECA > adenosine. Micromolar concentrations of DPCPX were required to antagonize the inhibition by adenosine and NECA of nerve-mediated responses, whereas the inhibitory effect of CPA was antagonized by nanomolar concentrations of the antagonist. 3 NECA and adenosine inhibited contractions induced by ATP (10 μm) or by NA (10 μm), NECA being at least ten fold more potent than adenosine, whereas CPA was inactive. Micromolar concentrations of DPCPX were required to antagonize the effect of adenosine on the contractions induced by ATP (10 μm). 4 Nerve-stimulated contractions could be observed in neonatal tissues from day 15 and increased with age, and could be inhibited by adenosine from this time, the potency of adenosine decreasing with age. Responses to ATP also appeared at day 15 and increased with age up to day 25, while responses to NA were present from day 10 (the earliest day tested) and decreased with age. 5 These results show that the rat vas deferens contains both prejunctional A1-receptors and postjunctional A2-receptors, and that adenosine acts on the latter populations to inhibit nerve-mediated contractions. The high potency of adenosine in the neonate and the parallel development of responses to ATP and to nerve-mediated contractions support suggestions that purinergic responses may be particularly important in neonatal tissues.Keywords
This publication has 24 references indexed in Scilit:
- Is there a basis for distinguishing two types of P2-purinoceptor?Published by Elsevier ,2002
- Noradrenaline-ATP co-transmission in the sympathetic nervous systemTrends in Pharmacological Sciences, 1991
- Noradrenaline and ATP as cotransmitters in sympathetic nervesNeurochemistry International, 1990
- Two phases of contractile response in rat isolated vas deferens and their regulation by adenosine and α-receptorsEuropean Journal of Pharmacology, 1989
- Adenosine: The prototypic neuromodulatorNeurochemistry International, 1989
- Role of adenine compounds in autonomic neurotransmissionPharmacology & Therapeutics, 1988
- Effects of α,β-methylene ATP on biphasic responses of rat vas deferensEuropean Journal of Pharmacology, 1987
- Adenosine receptors and calcium: Basis for proposing a third (A3) adenosine receptorProgress in Neurobiology, 1986
- STRUCTURE‐ACTIVITY RELATIONS FOR PRESYNAPTIC INHIBITION OF NORADRENERGIC AND CHOLINERGIC TRANSMISSION BY ADENOSINE: EVIDENCE FOR ACTION ON A1 RECEPTORSJournal of Autonomic Pharmacology, 1981
- Presynaptic Neuromodulation Mediated by Purinergic ReceptorsPublished by Springer Nature ,1981